Naltrexone Hydrochloride | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Naltrexone Hydrochloride
Canada

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

Faran Shimi Naltrexone Hydrochloride

Contact Supplier

Naltrexone Hydrochloride

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Naltrexone Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 9 USDMF, 8 CEP/COS, 2 EU WC, 7 KDMF, 46 NDC API, 19 Listed Suppliers, $ API Reference Price

26 API Suppliers
9 USDMF
8 CEP/COS
2 EU WC
7 KDMF
46 NDC API
19 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

14 Drugs in Development

14 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

48 FDF Dossiers, 23 FDA Orange Book, 14 Europe, 4 Canada, 2 South Africa, 5 Listed Dossiers

48 FDF Dossiers
23 FDA Orange Book
14 Europe
4 Canada
2 South Africa
5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 90MG;8MG, CAPSULE, EXTENDED RELEASE;ORAL - 100MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 20MG;0.8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 30MG;1.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 50MG;2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 60MG;2.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 80MG;3.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 90MG;8MG
CAPSULE, EXTENDED RELEASE;ORAL - 100MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, EXTENDED RELEASE;ORAL - 20MG;0.8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, EXTENDED RELEASE;ORAL - 30MG;1.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, EXTENDED RELEASE;ORAL - 50MG;2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, EXTENDED RELEASE;ORAL - 60MG;2.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, EXTENDED RELEASE;ORAL - 80MG;3.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 Evonik, 1 SPI Pharma, 2 Seqens, 8 DKSH, 4 Faran Shimi Pharmaceutical, 4 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 17 BASF, 1 Clariant, 18 Corel Pharma Chem, 6 DFE Pharma, 1 Finar, 10 Gangwal Chemicals, 9 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 35 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 10 Roquette, 12 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 3 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

63 Coating Systems & Additives, 52 Fillers, Diluents & Binders, 41 Controlled & Modified Release, 24 Thickeners and Stabilizers, 19 Granulation, 19 Solubilizers, 17 Direct Compression, 14 Disintegrants & Superdisintegrants, 14 Lubricants & Glidants, 13 Film Formers & Plasticizers, 12 Topical, 12 Parenteral, 11 Taste Masking, 9 Co-Processed Excipients, 9 Empty Capsules, 7 Emulsifying Agents, 5 API Stability Enhancers, 5 Coloring Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 3 Chewable & Orodispersible Aids

63 Coating Systems & Additives
52 Fillers, Diluents & Binders
41 Controlled & Modified Release
24 Thickeners and Stabilizers
19 Granulation
19 Solubilizers
17 Direct Compression
14 Disintegrants & Superdisintegrants
14 Lubricants & Glidants
13 Film Formers & Plasticizers
12 Topical
12 Parenteral
11 Taste Masking
9 Co-Processed Excipients
9 Empty Capsules
7 Emulsifying Agents
5 API Stability Enhancers
5 Coloring Agents
5 Rheology Modifiers
4 Vegetarian Capsules
4 Surfactant & Foaming Agents
3 Chewable & Orodispersible Aids

DIGITAL CONTENT

47 NEWS #PharmaBuzz

47 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 17 Finished Drug Prices

2 US Medicaid Prescriptions
17 Finished Drug Prices

MARKET PLACE

16 APIs, 3 FDF Dossiers

16 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

88 US Patents

88 US Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 7 Others

2 EDQM
7 Others

$ API Ref.Price (USD/KG) : 6,831 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

4 All

01 1APOTEX INC

02 1BAUSCH HEALTH, CANADA INC.

03 1STERINOVA INC.

04 1TEVA CANADA LIMITED

filter Active Ingredients Reset all filters

4 All

01 4NALTREXONE HYDROCHLORIDE

filter Dosage Form Reset all filters

4 All

01 3TABLET

02 1TABLET (EXTENDED-RELEASE)

filter Brand Name Reset all filters

4 All

01 1APO-NALTREXONE

02 1CONTRAVE

03 1NALTREXONE HYDROCHLORIDE TABLETS USP

04 1REVIA

List of Suppliers

Product Main Page

01

APOTEX INC

PharmScience R&D

Not Confirmed

APOTEX INC

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

NALTREXONE HYDROCHLORIDE

Brand Name : APO-NALTREXONE

Dosage Form : TABLET

Dosage Strength : 50MG

Packaging : 30/50

Approval Date :

Application Number : 2444275

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

BAUSCH HEALTH, CANADA INC.

PharmScience R&D

Not Confirmed

BAUSCH HEALTH, CANADA INC.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

NALTREXONE HYDROCHLORIDE

Brand Name : CONTRAVE

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 8MG

Packaging : 70/120

Approval Date :

Application Number : 2472945

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

STERINOVA INC.

PharmScience R&D

Not Confirmed

STERINOVA INC.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

NALTREXONE HYDROCHLORIDE

Brand Name : NALTREXONE HYDROCHLORIDE TABLETS USP

Dosage Form : TABLET

Dosage Strength : 50MG

Packaging : 28

Approval Date :

Application Number : 2451883

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

TEVA CANADA LIMITED

PharmScience R&D

Not Confirmed

TEVA CANADA LIMITED

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

NALTREXONE HYDROCHLORIDE

Brand Name : REVIA

Dosage Form : TABLET

Dosage Strength : 50MG

Packaging : 50

Approval Date :

Application Number : 2213826

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!